Mesalamine NDC 0832-6056

NDC codes

FDA NDC Directory

Product NDC (as listed)0832-6056Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00832-6056Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0832-6056-12	00832605612	120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0832-6056-12)Marketed from Jul 25, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mesalamine
Generic name (nonproprietary): mesalamine
Active ingredients: Mesalamine — .375 g/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Upsher-Smith Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217533
Marketing start: Jun 6, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 0832-6056_44e0cd4f-abe7-5e61-e063-6294a90a988bSPL ID 44e0cd4f-abe7-5e61-e063-6294a90a988bSPL set ID 1e6978d0-01db-477d-a90f-27561777480fRxCUI 825130UNII 4Q81I59GXCUPC 0308326056122
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400832605612 followed by a unit qualifier and the quantity

Package 00832-6056-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 1, 2025.

Indications (excerpt from the label)

Mesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults. Mesalamine extended-release capsules are an aminosalicylate indicated for the maintenance of remission of ulcerative colitis in adults. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217533

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217533
Product	Strength	Form · route	Labeler	Product NDC
Mesalamine	Mesalamine .375 g/1	Capsule, Extended releaseOral	Golden State Medical Supply, Inc.	51407-976